跳动心臟稳定器市场－全球产业规模、份额、趋势、机会和预测，按产品类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球跳动心臟稳定器市值为 2.6428 亿美元，预计到 2030 年将达到 3.7309 亿美元，年复合成长率(CAGR) 为 5.89%。该市场是更广泛的医疗器材产业中一个充满活力且快速发展的领域。跳动心臟稳定器，也称为心臟稳定器或心臟定位装置，是心臟手术中的重要工具，它使得在跳动的心臟上进行手术而无需进行心肺分流术 (CPB)。市场主要受到心血管疾病盛行率上升、外科技术进步以及人口老化加剧等因素的推动。

推动全球跳动心臟稳定器市场发展的关键因素是心血管疾病发生率的增加，包括冠状动脉疾病和心臟瓣膜疾病。这些情况通常需要手术干预，而跳动的心臟稳定器可以让外科医生在心臟继续跳动时进行手术，从而降低与 CPB 相关的风险。该技术由于其恢復时间更短、术后併发症更少等优势而获得了广泛的关注。

技术创新进一步推动了市场的成长。跳动心臟稳定器的设计和材料的进步增强了其功能性和易用性。这些设备现在有多种形式，包括机械稳定器、基于吸力的稳定器和机器人辅助稳定器，为外科医生提供满足不同手术需求的多种选择。

关键市场驱动因素

心血管疾病盛行率上升：

主要市场挑战

安全性和有效性问题：

主要市场趋势

微创心臟手术（MICS）：

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球心臟稳定器市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（真空稳定剂、机械稳定剂、其他）
  • 按应用（冠状动脉绕道手术（CABG）、先天性心臟缺陷手术、心房颤动手术、其他）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美跳动心臟稳定器市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲心臟稳定剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区心臟稳定器市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲跳动心臟稳定剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲跳动心臟稳定剂市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Terumo Cardiovascular Systems Corporation
• Medtronic PLC
• Visionary Medtech Solutions Pvt. Ltd.
• Getinge AB
• LivaNova PLC
• Guidant Corporation
• HTKD Medical.
• Chase Medical
• Edwards Lifesciences Corporation
• Atricure, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Beating Heart Stabilizers Market for Beating Heart Stabilizers was valued at USD 264.28 million in 2024 and is projected to reach USD 373.09 million by 2030, growing at a compound annual growth rate (CAGR) of 5.89%. This market is a dynamic and rapidly advancing segment within the broader medical device industry. Beating heart stabilizers, also referred to as cardiac stabilizers or cardiac positioning devices, are vital tools in cardiac surgery that enable procedures on a beating heart without the need for cardiopulmonary bypass (CPB). The market is primarily driven by factors such as the rising prevalence of cardiovascular diseases, advancements in surgical techniques, and the growing aging population.

A key factor propelling the global Beating Heart Stabilizers market is the increasing incidence of cardiovascular diseases, including coronary artery disease and valvular heart diseases. These conditions often require surgical intervention, and beating heart stabilizers allow surgeons to perform surgeries while the heart continues to beat, thereby reducing risks associated with CPB. This technique has gained significant traction due to its advantages, including shorter recovery times and fewer postoperative complications.

Technological innovations have further fueled the growth of the market. Advancements in the design and materials of beating heart stabilizers have enhanced their functionality and ease of use. These devices are now available in various forms, including mechanical stabilizers, suction-based stabilizers, and robotic-assisted stabilizers, offering surgeons a variety of options for different surgical needs.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases:

The global Beating Heart Stabilizers market is expanding due to the rising prevalence of chronic diseases, particularly cardiovascular conditions. Cardiovascular diseases (CVDs) are responsible for approximately 18 million deaths annually, highlighting the urgent need for effective surgical interventions. Beating heart stabilizers are critical for off-pump coronary artery bypass (OPCAB) surgeries, allowing surgeons to operate on a beating heart without cardiopulmonary bypass, which reduces complications and accelerates patient recovery. The increasing prevalence of CVDs, driven by aging populations and lifestyle changes, has intensified the demand for these stabilizers. Additionally, hypertension, a major risk factor for heart disease, affects around 1.3 billion people globally, with nearly half unaware of their condition, further emphasizing the need for advanced surgical solutions.

Key Market Challenges

Safety and Efficacy Concerns:

Beating heart stabilizers are complex, precision-engineered devices that require state-of-the-art technology and materials to ensure both safety and effectiveness. The high research and development costs associated with these devices often result in elevated prices, which can be a barrier for healthcare providers, particularly smaller hospitals or facilities in resource-limited regions. The high cost of beating heart stabilizers limits access to these advanced surgical tools, particularly in developing countries, and contributes to existing healthcare disparities. Patients in economically disadvantaged regions may have limited access to the latest treatment options, exacerbating inequalities in healthcare outcomes. Even in well-established healthcare systems, the acquisition of costly medical equipment can strain financial resources.

Key Market Trends

Minimally Invasive Cardiac Surgery (MICS):

Minimally invasive cardiac surgery has gained significant traction as a less invasive, patient-friendly alternative to traditional heart surgery. This trend is fueling the demand for beating heart stabilizers, as these devices are essential for performing complex procedures through smaller incisions. MICS offers patients benefits such as reduced postoperative pain, shorter hospital stays, and faster recovery times, making it a popular choice among both surgeons and patients. Beating heart stabilizers play a critical role in MICS by ensuring the stability and precision needed to operate on a beating heart, contributing to the success of these procedures. As healthcare continues to advance technologically, the demand for innovative tools like beating heart stabilizers is expected to grow, further solidifying their importance in modern cardiac surgery.

Key Market Players

• Terumo Cardiovascular Systems Corporation
• Medtronic PLC
• Visionary Medtech Solutions Pvt. Ltd.
• Getinge AB
• LivaNova PLC
• Guidant Corporation
• HTKD Medical.
• Chase Medical
• Edwards Lifesciences Corporation
• Atricure, Inc.

Report Scope:

In this report, the Global Beating Heart Stabilizers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Beating Heart Stabilizers Market, By Product Type:

• Vacuum based Stabilizers
• Mechanical Stabilizers
• Others

Beating Heart Stabilizers Market, By Application:

• Coronary Artery Bypass (CABG)
• Congenital Heart Defect Surgeries
• Atrial fibrillation surgery
• Others

Beating Heart Stabilizers Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centres
• Others

Beating Heart Stabilizers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Beating Heart Stabilizers Market.

Available Customizations:

Global Beating Heart Stabilizers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Beating Heart Stabilizers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Vacuum based Stabilizers, Mechanical Stabilizers, Others)
  • 5.2.2. By Application (Coronary Artery Bypass (CABG), Congenital Heart Defect Surgeries, Atrial fibrillation surgery, Others)
  • 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centres, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Beating Heart Stabilizers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Beating Heart Stabilizers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End user
  • 6.3.2. Mexico Beating Heart Stabilizers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End user
  • 6.3.3. Canada Beating Heart Stabilizers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End user

7. Europe Beating Heart Stabilizers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Beating Heart Stabilizers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End user
  • 7.3.2. Germany Beating Heart Stabilizers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Beating Heart Stabilizers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Beating Heart Stabilizers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Beating Heart Stabilizers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End user

8. Asia-Pacific Beating Heart Stabilizers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Beating Heart Stabilizers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End user
  • 8.3.2. India Beating Heart Stabilizers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End user
  • 8.3.3. South Korea Beating Heart Stabilizers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End user
  • 8.3.4. Japan Beating Heart Stabilizers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Beating Heart Stabilizers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End user

9. South America Beating Heart Stabilizers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Beating Heart Stabilizers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End user
  • 9.3.2. Argentina Beating Heart Stabilizers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End user
  • 9.3.3. Colombia Beating Heart Stabilizers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End user

10. Middle East and Africa Beating Heart Stabilizers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Beating Heart Stabilizers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End user
  • 10.3.2. Saudi Arabia Beating Heart Stabilizers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End user
  • 10.3.3. UAE Beating Heart Stabilizers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Terumo Cardiovascular Systems Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic PLC
• 15.3. Visionary Medtech Solutions Pvt. Ltd.
• 15.4. Getinge AB
• 15.5. LivaNova PLC
• 15.6. Guidant Corporation
• 15.7. HTKD Medical.
• 15.8. Chase Medical
• 15.9. Edwards Lifesciences Corporation
• 15.10. Atricure, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer